Tax included.
The Pharma Legal Handbook: META contains 9 comprehensive country legal guides and answers essential questions about the legal and regulatory environment for pharmaceutical companies in META(Middle East, Africa & Turkey). It is a must-have for any company operating in the continent or looking to enter the market.
Countries featured:
Algeria, Egypt, Iraq, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates & Zimbabwe
Prepared in association with some of the continent's leading law firms, The Pharma Legal Handbook: META should answer any questions linked to regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents, cannabinoid medicines, medical cannabis and opioid drugs.
Brand-new chapters for 2024: Iraq
Publisher: White Publishing Resources
The Pharma Legal Handbook: Asia consists of a zipped folder containing 8 individual Pharma Legal Handbook PDF files (contributing legal partners in parenthesis):
Algeria (SAARPE)
Egypt (Youssry Saleh)
Nigeria (Olaniwun Ajayi LP)
Saudi (STA)
South Africa (Fasken)
Turkey (Moroğlu Arseven)
UAE (STA)
Zimbabwe (Honey & Blanckenberg)
Publication Date: December 2021
Updated Compilation: December 2022
China
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
India
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Orphan Drugs & Rare Diseases
- Localization
- Biosimilars & Biologics
Indonesia
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Localization
Japan
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Orphan Drugs & Rare Diseases
Malaysia
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
Singapore
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Orphan Drugs & Rare Diseases
- Localization
- Biosimilars & Biologics
Thailand
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Orphan Drugs & Rare Diseases
- Localization
- Biosimilars & Biologics
Vietnam
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms